PDCD1 and neoplasm: The immunological checkpoints selected for the analysis, such as PD-1/PD-L1, CTLA-4/CD86, and CD200R/CD200, play a significant role in regulating the immune response in many diseases, including cancer, and influencing the tumor microenvironment.